Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

Carcinogenesis

Volumn 26, Issue 2, 2005, Pages 271-279

  Fujita, Mamoru ^a   Hayashi, Izumi ^a   Yamashina, Shohei ^a   Fukamizu, Akiyoshi ^b   Itoman, Moritoshi ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 1A RECEPTOR; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LISINOPRIL; PROTEIN KINASE C; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VANDETANIB; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FIBROBLAST; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STROMA; TUMOR GROWTH; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; FIBROBLASTS; LISINOPRIL; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; PROTEIN KINASE C; RECEPTOR, ANGIOTENSIN, TYPE 1; SARCOMA; SIGNAL TRANSDUCTION; TETRAZOLES; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 13844255555     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh324     Document Type: Article

References (47)

1. Folkman,J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst., 82, 4-6.
2. Folkman,J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
3. Hanahan,D. and Folkman,J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
4. Tamarat,R., Silvestre,J.S., Durie,M. and Levy,B.I. (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab. Invest., 82, 747-756.
5. Sasaki,K., Murohara,T., Ikeda,H., Sugaya,T., Shimada,T., Shintani,S. and Imaizumi,T. (2002) Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest., 109, 603-611.
6. Muramatsu,M., Katada,J., Hayashi,I. and Majima,M. (2000) Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J. Biol. Chem., 275, 5545-5552.
7. + exchange and stimulates growth in cultured vascular smooth muscle cells. J. Hypertens., 6 (suppl.), S438-S441.
8. Bell,L. and Madri,J.A. (1990) Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am. J. Pathol. 137, 7-12.
9. Paquet,J.L., Baudouin-Legros,M., Brunelle,G. and Meyer,P. (1990) Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J. Hypertens., 8, 565-572.
10. Nadal,J.A., Scicli,G.M., Carbini,L.A., Nussbaum,J.J. and Scicli,A.G. (1999) Angiotensin II and retinal pericytes migration. Biochem. Biophys. Res. Commun., 266, 382-385.
11. Otani,A., Takagi,H., Oh,H., Suzuma,K., Matsumura,M., Ikeda,E. and Honda,Y. (2000) Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Invest. Ophthalmol. Vis. Sci., 41, 1192-1199.
12. Fernandez,L.A., Tarlatzis,B.C., Rzasa,P.J., Caride,V.J., Laufer,N., Negro-Vilar,A.F., DeCherney,A.H. and Naftolin,F. (1985) Renin-like activity in ovarian follicular fluid. Fertil. Steril., 44, 219-223.
13. Le Noble,F.A., Hekking,J.W., Van Straaten,H.W., Slaaf,D.W. and Struyker Boudier,H.A. (1991) Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol., 195, 305-306.
14. Andrade,S.P., Cardoso,C.C., Machado,R.D. and Beraldo,W.T. (1996) Angiotensin-II-induced angiogenesis in sponge implants in mice. Int. J. Microcirc. Clin. Exp., 16, 302-307.
15. Hu,D.E., Hiley,C.R. and Fan,T.P. (1996) Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br. J. Pharmacol., 117, 545-551.
16. Kim,S. and Iwao,H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev., 52, 11-34.
17. Lever,A.F., Hole,D.J., Gillis,C.R. et al. (1998) Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet, 352, 179-184.
18. Jones,P.H., Christodoulos,K., Dobbs,N. et al. (2004) Combination antiangiogenesis therapy with marimastat, captpril and fragmin in patients with advanced cancer. Br. J. Cancer, 91, 30-36.
19. Silber,J.H., Cnaan,A., Clark,B.J. et al. (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J. Clin. Oncol., 22 820-828.
20. Amano,H., Hayashi,I., Endo,H. et al. (2003) Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med., 197, 221-232.
21. Sugaya,T., Nishimatsu,S., Tanimoto,K. et al. (1995) Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J. Biol. Chem., 270, 18719-18722.
22. Fujita,M., Hayashi,I., Yamashina,S., Itoman,M. and Majima,M. (2002) Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis and metastasis. Biochem. Biophys. Res. Commun. 294, 441-447.
23. Shibouta,Y., Inada,Y., Ojima,M. et al. (1993) Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974) and its prodrug, (+/-)-1-(cyclohexyloxy-carbonyloxy)-ethyl 2-ethoxy-1-[[2′- (1H-tetrazol-5-yl biphenyl-4-yl]-methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther., 266, 114-120.
24. Wedge,S.R., Ogilvie,D.J., Dukes,M. et al. (2002) ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis and tumor growth following oral administration. Cancer Res., 62, 4645-4655.
25. Yoshiji,H., Kuriyama,S., Kawata,M., Yoshi,J., Ikenaka,Y., Noguchi,R., Nakatani,T., Tsujinoue,H. and Fukui,H. (2001) The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin. Cancer Res., 7, 1073-1078.
26. Williams,C.S., Tsujii,M., Reese,J., Dey,S.K. and DuBois,R.N. (2000) Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest., 105, 1589-1594.
27. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
28. Hoffmann,A. and Cool,D.R. (2003) Angiotensin II receptor types 1A, 1B and 2 in murine neuroblastoma Neuro-2a cells. J. Recept. Signal Transduct. Res., 23, 111-121.
29. Huang,J., Hara,Y., Anrather,J., Speth,R.C., Iadecola,C. and Pickel,V.M. (2003) Angiotensin II subtype 1A (AT1A) receptors in the rat sensory vagal complex: subcellular localization and association with endogenous angiotensin. Neuroscience, 122, 21-36.
30. Katada,J., Muramatsu,M., Hayashi,I., Tsutsumi,M., Konishi,Y. and Majima,M. (2002) Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J. Pharmacol. Exp. Ther., 302, 949-956.
31. Muramatsu,M., Katada,J., Hattori,M., Hayashi,I. and Majima,M. (2000) Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol., 402, 181-191.
32. Hayashi,I., Amano,H., Yoshida,S. et al. (2002) Suppressed angiogenesis in kininogen-deficiencies. Lab. Invest., 82, 871-880.
33. Yoshida,S., Amano,H., Hayashi,J., Kitasato,H., Kamata,M., Inukai,M., Yoshimura,H. and Majima,M. (2003) COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab. Invest., 83, 1385-1394.
34. Majima,M., Amano,H. and Hayashi,I. (2003) Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol. Sci., 24, 524-529.
35. Tsujii,M., Kawano,S., Tsuji,S., Sawaoka,H., Hori,M. and DuBois,R.N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
36. Kim,K.J., Li,B., Winer,J., Armanini,M., Gillett,N., Phillips,H.S. and Ferrara,N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
37. Majima,M., Hayashi,I., Muramatsu,M., Katada,J., Yamashina,S. and Katori,M. (2000) Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol., 130, 641-649.
38. Amano,H., Ando,K., Minamida,S., Hayashi,I., Ogino,M., Yamashina,S., Yoshimura,H. and Majima,M. (2001) Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn. J. Pharmacol., 87, 181-188.
39. Chua,C.C., Hamdy,R.C. and Chua,B.H. (1998) Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta, 1401, 187-194.
40. Shima,D.T., Kuroki,M., Deutsch,U., Ng,Y.S., Adamis,A.P. and D'Amore,P.A. (1996) The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem., 271, 3877-3883.
41. Hartford,A.C., Gohongi,T., Fukumura,D. and Jain,R.K. (2000) Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res., 60, 2128-2131.
42. Gohongi,T., Fukumura,D., Boucher,Y., Yun,C.O., Soff,G.A., Compton,C., Todoroki,T. and Jain,R.K. (1999) Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nature Med., 5 1203-1208.
43. Gupta,R.A. and Dubois,R.N. (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev. Cancer, 1, 11-21.
44. Egami,K., Murohara,T., Shimada,T. et al. (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J. Clin. Invest., 112, 67-75.
45. Coussens,L.M. and Werb,Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
46. Mantovani,A., Sozzani,S., Locati,M., Allarena,P. and Sica,A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 23, 549-555.
47. Greenlee,R.T., Hill-Harmon,M.B., Murray,T. and Thun,M. (2001) Cancer statistics, 2001. CA Cancer J. Clin., 51, 15-36.